Details

Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo
ID Reitmeier, Matjaž (Author), ID Mrvar, Primož (Mentor) More about this mentor... This link opens in a new window

.pdfPDF - Presentation file, Download (1,52 MB)
MD5: 9CF96B800394DED7426B558EF89EC742
PID: 20.500.12556/rul/a7502131-25aa-4ae6-bb58-b162c386a326

Language:Slovenian
Keywords:tlačno litje, aluminijeve zlitine, karakterizacija, kakovost
Work type:High school thesis
Typology:2.11 - Undergraduate Thesis
Organization:NTF - Faculty of Natural Sciences and Engineering
Place of publishing:Ljubljana
Publisher:[M. Reitmeier]
Year:2016
Number of pages:V, 34 f.
PID:20.500.12556/RUL-89035 This link opens in a new window
UDC:621.74
COBISS.SI-ID:1646943 This link opens in a new window
Publication date in RUL:10.02.2017
Views:3046
Downloads:413
Metadata:XML DC-XML DC-RDF
:
REITMEIER, Matjaž, 2016, Karakterizacija in kakovost aluminijevih zlitin za tlačno litje : diplomsko delo [online]. Bachelor’s thesis. Ljubljana : M. Reitmeier. [Accessed 27 March 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=89035
Copy citation
Share:Bookmark and Share

Similar documents

Similar works from RUL:
  1. Display of macrophage specific membrane markers in mRNA overexpressing cells in non-small cell lung cancer
  2. Development of the immunohistochemical method for the cellular marker CD204 on cells with high expression of lipoprotein lipase in non-small cell lung cancer tissue
  3. Study of phosphatidylethanolamine N-methyltransferase gene expression in non-small cell lung cancer tissue
  4. Development of procedure for macrophage isolation from non-small cell lung cancer and their phenotypization
  5. Preučevanje ekspresije gena za LDL receptor v nedrobnoceličnem pljučnem rakavem tkivu
Similar works from other Slovenian collections:
  1. Novosti v zdravljenju pljučnega raka ASCO, Chicago, 1.-5. junij 2012
  2. Nove podobe pljučnega raka
  3. Naše izkušnje s citostatskim zdravljenjem drobnoceličnega pljučnega raka
  4. Osimertinib za zdravljenje nedrobnoceličnega pljučnega raka
  5. Gefitinib za zdravljenje nedrobnoceličnega pljučnega raka

Back